Johnson & Johnson (JNJ)
163.36
+0.42 +0.26%
NYSE
Dec 7, 16:00
163.50
+0.14 +0.09%
Pre-Market: 05:46
USD
Johnson & Johnson Market Cap:
430.06B for Dec. 7, 2021View 4,000+ financial data types
Browse...
View Full Chart
Market Cap Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Historical Market Cap Data
View and export this data going back to 1984.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| Dec. 7, 2021 | 430.06B |
| Dec. 6, 2021 | 428.96B |
| Dec. 3, 2021 | 419.58B |
| Dec. 2, 2021 | 413.55B |
| Dec. 1, 2021 | 416.16B |
| Nov. 30, 2021 | 410.50B |
| Nov. 29, 2021 | 420.56B |
| Nov. 26, 2021 | 419.11B |
| Nov. 24, 2021 | 421.85B |
| Nov. 23, 2021 | 423.03B |
| Nov. 22, 2021 | 420.43B |
| Nov. 19, 2021 | 428.82B |
| Nov. 18, 2021 | 427.53B |
| Nov. 17, 2021 | 429.85B |
| Nov. 16, 2021 | 428.24B |
| Nov. 15, 2021 | 430.48B |
| Nov. 12, 2021 | 434.40B |
| Nov. 11, 2021 | 429.27B |
| Nov. 10, 2021 | 432.46B |
| Nov. 9, 2021 | 427.82B |
| Nov. 8, 2021 | 428.77B |
| Nov. 5, 2021 | 430.25B |
| Nov. 4, 2021 | 433.33B |
| Nov. 3, 2021 | 434.54B |
| Nov. 2, 2021 | 435.93B |
| Nov. 1, 2021 | 429.17B |
| Oct. 29, 2021 | 428.80B |
| Oct. 28, 2021 | 428.72B |
| Oct. 27, 2021 | 431.06B |
| Oct. 26, 2021 | 436.35B |
| Oct. 25, 2021 | 431.96B |
| Oct. 22, 2021 | 431.01B |
| Oct. 21, 2021 | 430.15B |
| Oct. 20, 2021 | 431.15B |
| Oct. 19, 2021 | 431.39B |
| Oct. 18, 2021 | 421.51B |
| Oct. 15, 2021 | 424.62B |
| Oct. 14, 2021 | 421.49B |
| Oct. 13, 2021 | 419.09B |
| Oct. 12, 2021 | 415.12B |
| Oct. 11, 2021 | 421.86B |
| Oct. 8, 2021 | 423.65B |
| Oct. 7, 2021 | 424.73B |
| Oct. 6, 2021 | 420.96B |
| Oct. 5, 2021 | 420.09B |
| Oct. 4, 2021 | 419.14B |
| Oct. 1, 2021 | 422.43B |
| Sept. 30, 2021 | 425.15B |
| Sept. 29, 2021 | 431.78B |
| Sept. 28, 2021 | 428.59B |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
Advertisement
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 68.30B |
| Moderna Inc | 114.48B |
| Amgen Inc | 119.03B |
Market Cap Range, Past 5 Years
| Minimum | 293.00B | Mar 23 2020 |
| Maximum | 472.45B | Aug 17 2021 |
| Average | 374.93B |
Market Cap Related Metrics
| PE Ratio | 24.42 |
| PS Ratio | 4.774 |
| PEG Ratio | 4.706 |
| Price to Book Value | 6.120 |
| Price | 163.36 |
| Earnings Yield | 4.10% |
| PEGY Ratio | 3.149 |
| Operating PE Ratio | 18.39 |
| Normalized PE Ratio | 21.57 |
News
Legend Biotech Submits New Drug Application for Myeloma CAR-T Therapy to Japanese Regulator
MT Newswires 12/07 10:36 ET
MT Newswires 12/07 10:36 ET
Biden calls on Senate to pass legislation to tackle 'outrageously expensive' drug prices
SA Breaking News 12/06 15:50 ET
SA Breaking News 12/06 15:50 ET
COVID testing remains 'troublesome' in various areas of the U.S., doctor explains
Yahoo 12/06 13:54 ET
Yahoo 12/06 13:54 ET
Is Johnson & Johnson Stock A Buy As It Plans To Separate Its Consumer Health Unit?
Yahoo 12/06 11:01 ET
Yahoo 12/06 11:01 ET
Legend Biotech Submits New Drug Application for Myeloma Therapy to Japanese Regulator
MT Newswires 12/06 09:55 ET
MT Newswires 12/06 09:55 ET
NDA for J&J's cilta-cel for multiple myeloma submitted to Japanese regulators
SA Breaking News 12/06 09:19 ET
SA Breaking News 12/06 09:19 ET
Advertisement
